主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACAD
#1237
Acadia Pharmaceuticals Inc.
24.5
6
+1.24%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.24%
每月变动
-6.83%
6个月变化
-7.08%
年变化
+28.05%
前一天收盘价
24.2
6
Open
24.5
6
Bid
Ask
Low
24.5
6
High
24.5
6
交易量
140
市场
股票
医疗保健
ACAD
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
新闻
Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs (ACAD)
ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
Jefferies上调Acadia Pharmaceuticals目标价,基于公司业绩指引
Jefferies raises Acadia Pharmaceuticals stock price target on guidance
Citizens上调Acadia Pharmaceuticals目标价,看好其增长前景
Citizens raises Acadia Pharmaceuticals price target on growth outlook
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-02-25
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
ACADIA Q4 2025 slides: $1B revenue milestone as both drugs post double-digit growth
Acadia财报即将公布:尽管利润承压但营收有望增长
Wolfe Research首次覆盖Acadia股票,给予跑赢大盘评级